Current Mesothelioma News and Events | Page 5

Current Mesothelioma News and Events, Mesothelioma News Articles.
Sort By: Most Relevant | Most Viewed
Page 5 of 5 | 188 Results
9/11 search-and-rescue dogs exhibit few effects from exposure to disaster sites
The search-and-rescue dogs deployed following the Sept. 11, 2001, terrorist attacks have not suffered either immediate or short-term effects from exposure to the disaster sites. For the last three years, University of Pennsylvania School of Veterinary Medicine researchers tracked the health of 97 of 212 identified dogs deployed at the 9/11 disaster sites. Neither the death rate nor the cancer rate among the deployed dogs is different from that of the control group. (2004-09-15)

USC/Norris Cancer researchers show potential of fighting angiogenesis
New drug results for fighting cancer reported at ASCO this past weekend. (2004-06-07)

New research outlines public health consequences
Longitudinal studies of firefighters, rescue workers and other personnel who responded to the collapse of the World Trade Center following the September 11, 2001 attacks have confirmed the presence of a positive relationship between the intensity and duration of their exposures to airborne pollutants and the severity of their pulmonary symptoms. (2004-05-03)

Zengen's new study reviews novel approach to control inflammation using melanocortin receptors
Zengen, Inc. announced today that its researchers have discovered that activation of melanocortin receptors (MCR) subtypes MC1R and MC3R could be a novel strategy to control inflammatory disorders. (2004-03-03)

Asbestos cancer breakthrough
Researchers at the Pacific Northwest Research Institute (PNRI) have reported the development of a blood test for mesothelioma, a highly aggressive lung cancer caused by asbestos exposure. (2003-11-13)

Early promise of blood marker to detect mesothelioma
Preliminary results of a study in this week's issue of The Lancet suggest that a blood test could be used in the future to identify people with mesothelioma-the usually deadly malignant tumor of mesothelial tissue surrounding the lungs, often caused by exposure to asbestos. (2003-11-13)

Drug combination extends survival in mesothelioma
Patients with pleural mesothelioma live longer and have less pain and shortness of breath when treated with a combination of cisplatin and pemetrexed. This drug combination caused the cancer to shrink in 41 percent of patients. This is the first therapy to show a benefit for this type of cancer. (2003-07-14)

Other highlights of the April 16 JNCI
Other highlights in the April 16 issue of JNCI include a study of follow-up rates in patients with bladder cancer, a study of a gene expression test for pleural mesothelioma, a clinical trial of bestatin for stage I small-cell lung cancer, a study of apoptosis in colon cancer cells, and a study of a gene mutation in papillary thyroid cancer. (2003-04-15)

Contaminated poliovirus vaccine not associated with cancer
Exposure to poliovirus vaccine that was contaminated with simian virus 40 (SV40) does not appear to be associated with increased cancer incidence in Denmark, according to a large population-based study appearing in the April 2 issue of the Journal of the National Cancer Institute. (2003-04-01)

Exposure to contaminated poliovirus vaccine not likely linked to rare cancer
The poliovirus vaccine used in mass immunization programs in the late 1950s and early 1960s was contaminated with the monkey virus SV40, which has been detected in some human tumors, particularly pleural mesothelioma. However, the rise in incidence of pleural mesothelioma between 1975 and 1997 is not likely the result of immunization with the SV40-contaminated vaccine, according to an analysis in the January 1 issue of the Journal of the National Cancer Institute. (2002-12-31)

Beijing conference to address lung cancer crisis in China
The first international lung cancer conference to be held in China will take researchers to Beijing October 27-30. UCSF, in collaboration with the University of Colorado Health Sciences Center and the Chinese Academy of Medical Sciences, is sponsoring the event. (2002-10-23)

New drug boost for asbestos-related lung cancer sufferers
Clinical trials of a new anticancer drug combination carried out by researchers at Newcastle University show that it has potential to almost double the life expectancy of sufferers of Mesothelioma - a form of lung cancer which affects around 1,700 people in the UK every year - according to a report published in the Journal of Clinical Oncology. (2002-08-13)

Molecularly targeted drug slows tumor growth in patients
Researchers from the National Cancer Institute (NCI) reported today that the molecularly targeted drug bevacizumab slowed tumor growth in patients with metastatic renal cell carcinoma, the most common form of kidney cancer in adults. The findings from their randomized clinical trial were presented at the American Society for Clinical Oncology meeting in Orlando, Fla. (2002-05-19)

UT Southwestern researchers link human lymphomas to polio vaccine tainted with monkey virus
UT Southwestern researchers have established a link between human non-Hodgkins lymphomas and a monkey virus carried by some people, possibly opening new avenues for detection, prevention and treatment. (2002-03-07)

SV40 found in human lymphoma samples
Evidence of simian virus 40 (SV40) infection found in 42 percent of non-Hodgkin lymphoma samples could shed new light on the genesis of these blood cancers that have become more common over the past 30 years, said Baylor College of Medicine scientists in a report in the March 9 issue of The Lancet, a British scientific journal. About 55,000 new cases of the disease are diagnosed annually (2002-03-07)

Discoveries in radiation oncology and cancer treatment presented at annual ASTRO meeting
Following are highlights from research presented by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) during this week's annual meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO). (2001-11-08)

A time bomb in the lungs: the ravages of asbestos - Industrialized as well as developing countries under threat
It is estimated that in the industrialized countries alone, 30,000 new cases of asbestos-related cancer are occurring annually, and that almost one person in seven might bear the scars of asbestos exposure. Over two million tons of the cheap mineral fibre, increasingly unpopular in the wealthier countries, continue to be produced every year, so we can begin to imagine what is in store for the less developed countries. (2001-09-24)

USC researchers find cancer-growing role for blood-vessel protein
A key protein in the growth and survival of new blood vessels--a process called angiogenesis--can also directly promote the growth and survival of malignant tumor cells, according to research done by scientists at the Keck School of Medicine of the University of Southern California. (2001-09-18)

Preclinical data of Introgen's INGN 241 demonstrate broad anti-cancer activity in multiple tumor types as monotherapy and in combination
Introgen reports preclinical findings demonstrating that INGN 241, an Adenoviral vector encoding the mda-7 gene can inhibit cell growth in multiple tumor types when used alone or in combination with established therapies. These data were presented as three separate studies at the Meeting of the American Society for Gene Therapy. (2001-06-01)

Malignant mesothelioma - therapeutic options and role of SV40
This meeting will focus on the recent studies demonstrating that simian virus 40 (SV40) is associated with a significant portion of human mesotheliomas as well as brain and bone tumors. (2001-04-09)

Fox Chase Cancer Center's Joseph Testa receives 1999 Irving J. Selikoff Award for Cancer Research
Dr. Joseph R. Testa, a cancer geneticist at Fox Chase Cancer Center, Philadelphia, has received a 1999 Irving J. Selikoff Award for Cancer Research. The award, given by the Ramazzini Institute for Occupational and Environmental Health Research, honors Testa for (1999-12-02)

UW-Madison Center One Of Two Sites Nationwide Selected For Clinical Trial Of Cancer Drug
The University of Wisconsin Comprehensive Cancer Center has been chosen as one of two sites in the nation to conduct human tests of endostatin, a promising potential cancer treatment that seems to work in part by disrupting the growth of blood vessels that nourish tumor cells. (1999-03-19)

Jefferson Scientists Suppress Tumor Growth In Animals, Aiming At Gene Therapy
Scientists at Jefferson Medical College believe they have found a potential target for gene therapy trials for lung cancer. They have demonstrated for the first time in laboratory animals that a normally protective anticancer gene, pRb2/p130, can actually block tumors from growing. (1998-10-06)

PENN Researchers Find That Pet Imaging Sheds More Light On Complex, Microscopic Cancers
In cancers based in unusual locations (in the lining of the lung-mesothelioma- or in lymph nodes), conventional imaging technology cannot detect malignant cells or differentiate them from non-cancerous ones. Researchers have shown the advantages of using positron emission tomography over structural imaging, including X-Ray, magnetic resonance imaging, and computerized tomography. (1998-09-10)

How A Common Protein Becomes A Cancer Killer
In one of nature's remarkable flukes, scientists in 1991 discovered a protein in frog eggs that proved to be a potent killer of cancer cells. Now a new study by a University of Wisconsin-Madison biochemist finds that a (1998-08-31)

Penn Researchers Initiate Ground-Breaking New Trials To Treat
Surgeons and radiation oncologists at the University of Pennsylvania Medical Center have recently initiated ground- breaking new protocols to treat advanced lung cancer and mesothelioma for patients who are considered untreatable at other institutions. Trials are applying innovative combination treatments with photodynamic therapy (light delivery) and surgery for patients. (1998-01-12)

Further Proof That An Altered Rb-2/p130 Gene Leads To Lung Cancer
Cancer researchers at Jefferson Medical College are gathering further evidence that damage to a powerful tumor- suppressor gene may lead to lung cancer. The research may lead to a new lung cancer tumor-grading test that enables physicians to gauge cancer aggressiveness, allowing them to develop more specific treatments. (1997-10-03)

Jefferson Scientists Discover Mechanism Of Viral Link To Disease Commonly Associated With Asbestos
Researchers at Jefferson Medical College have discovered how a monkey virus may lead to a rare cancer normally tied to asbestos exposure. Antonio Giordano and his colleagues report that simian virus 40 inactivates key tumor suppressor proteins, possibly leading to the development of mesothelioma. (1997-07-29)

Page 5 of 5 | 188 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to